Jianfeng Group (600668.SH) subsidiary obtained compound topicamide eye drops drug registration certificate

Zhitongcaijing · 2d ago

Zhitong Finance App News, Jianfeng Group (600668.SH) issued an announcement. Recently, Zhejiang Jianfeng Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for compound topicamide eye drops approved and issued by the State Drug Administration. Topicamide is a synthetic derivative of tropinic acid. It is an M-choline receptor blocker with effects similar to atropine. Phenylephrine is an adrenaline alpha receptor stimulant that has a pupil dilating effect. This product is used to dilate pupils and control paralysis for the purpose of diagnosis and treatment.